The neurons of the central nervous system (CNS) are enclosed within an astrocytic environment. This glial environment has a distinct surface beneath the meninges and around blood vessels where the astrocyte surface which constitutes the boundary is coated by basement membrane to form a structure termed the glia limitans. Within the astrocyte-bounded CNS, axons are myelinated by oligodendrocytes; as axons leave the CNS they become associated with Schwann cells. In normal circumstances there is a clear separation of the two forms of glial-axonal In an attempt to address this last issue we have under taken a series of experiments in which various glial cell
glial cell transplantation as a means of influencing repair in the central nervous system of man. A crucial step in developing human therapy is to establish whether know ledge gained from studies in rodents is applicable to larger mammalian species. In order to explore this issue we examined the ability of cat glial cell cultures to remyel inate areas of ethidium-bromide-induced demyelination in the spinal cord of immunosuppressed rats and cats.
Transplantation of density-gradient-isolated glial cells obtained from the forebrain of7-day-old kittens resulted in enhanced oligodendrocyte remyelination in the rat but failed to enhance oligodendrocyte remyelination in the cat. The feasibility of enhancing oligodendrocyte remyel ination in the cat lesion was demonstrated by trans planting a rat culture containing a high proportion of cells of the oligodendrocyte lineage. Tissue culture of the density-gradient-isolated cell preparations suggested that the failure of the kitten glial preparation to enhance oligodendrocyte remyelination in the cat was most prob ably due to its poor oligodendrocyte-generating capacity.
However, our lack of understanding of the biology of feline glial cells precludes a full understanding of these experiments.
The neurons of the central nervous system (CNS) are enclosed within an astrocytic environment. This glial environment has a distinct surface beneath the meninges and around blood vessels where the astrocyte surface which constitutes the boundary is coated by basement membrane to form a structure termed the glia limitans. Within the astrocyte-bounded CNS, axons are myelinated by oligodendrocytes; as axons leave the CNS they become associated with Schwann cells. In normal circumstances there is a clear separation of the two forms of glial-axonal its original location, the consequence of which is that In an attempt to address this last issue we have under taken a series of experiments in which various glial cell preparations have been injected into areas of demyel ination in cats and rats.
METHODS

Isolation of Glial Cell from Postnatal 7-day-old Cat Forebrain
Immediately after euthanasia with an intraperitoneal injection of pentobarbitone sodium the forebrain of a 7 -day-old kitten was removed and placed in cold Eagle's minimal essential medium containing 20 mM Hepes (MEM/HEPES) and then transferred into calcium-and magnesium-free Hanks buffered salt solution (Hanks) for removal of the meninges and choroid plexi using a dissec ting microscope. The tissue was chopped roughly into 1 mm3 blocks and digested with trypsin (0.25%) and DNase (SO JLg/ml) in Hanks for 45 minutes. The trypsin was inactivated by the addition of 20% by volume fetal calf serum and the tissue fragments sedimented and resus pended in Dulbecco' s modified Eagle's medium (DMEM) containing 0.6% glucose. The tissue was triturated and fil tered (ISO and 80 JLm mesh size) and placed onto a 25% Perc 011 density gradient and centrifuged at 22 000 r.p.m. for 45 minutes. The entire layer between the myelin debris band and the red cell band was harvested. The Perc oil was removed by repeated sedimentation and res us pension in MEM/HEPES medium. The cells were either prepared directly for transplantation, or plated onto poly-d-Iysine coated tissue culture flasks at a density of 105 cells/cm". The cells were incubated under 5% CO, at 37°C in modi fied DMEM containing 10% fetal calf serum, 80% of which was replaced weekly.
Cell cultures were immunostained using a panel of anti bodies normally used to characterise rodent glial cell cul tures, where 01 identifies cells committed to become 0ligodendrocytes,6 04 identifies proligodendrocytes and oligodendrocytes/ A2BS identifies 0-2A progenitors and type 2 astrocytes,8 and GFAP identifies astrocytes. For immunostaining, 1 cm" areas of the tissue culture plastic were marked out with a hydrophilic marker pen (DAKO) and 01, 04 or A2BS primary mouse antibodies applied to individual areas for 30 minutes at 37°C. The areas were then washed with Hanks medium and fixed with 4% para formaldehyde in phosphate-buffered saline (PBS). Secon dary anti-mouse IgM antibody conjugated to fluorescein was then applied. After permeabilisation of the cells with 0.03% Nonidet P40 in PBS, primary antibody to GFAP (DAKO) was applied to all the areas and a secondary anti rabbit antibody conjugated to rhodamine applied. Finally all the selected areas were stained with bisbenzimide H-332S8 10 JLg/ml to visualise nuclei. Areas within the triple-labelled regions were then selected at random and photographed under phase contrast and fluorescence ill umination with three filter sets appropriate for demonstra ting the three fluorescence reagents used. The four photographs for each field were overlaid with a grid and the percentage of cells staining with each antibody deter mined. The cell culture analysis was carried out at the time of each transplantation and perfusion.
Examination of the Remyelinating Potential of the Cat Glial Cells in X-irradiated Ethidium Bromide Lesions in the Rat
Cells were injected into demyelinating lesions made in the locally X-irradiated spinal cord of immunosuppressed rats. Such lesions have no repair capacity and thus any repair seen following the injection of cells can be related to the introduced cells. In order to suppress host repair responses the spinal cord between TIl and L2 was X-irradiated with 40 G using previously documented methods.9 Three days later 1 JLl of 0.1 % ethidium bromide (EB) was injected into the dorsal columns at L1 and a further 3 days later 1 JLl of cell suspension that had been in culture for 0,7, 14 or 21 days was injected into the areas of spinal cord previously injected with EB in groups of 6 rats. Four animals in each group were maintained on cyclospo rin (IS mg/kg per day by subcutaneous injection) while 2 animals received no cyclosporin. Each group of rats was maintained for 21 days and then perfused with 4% glut araldehyde in phosphate buffer and 1 mm transverse slices taken through the lesion area for routine processing into resin. Sections 1 JLm thick were cut from the resin blocks and stained with alkaline toluidine blue. Some sec tions were stained with GF AP antibodies following remo val of resin and selected areas trimmed and examined by electron microscopy.
Examination of the Remyelinating Potential of Transplanted Glial Cells in Ethidium Bromide
Lesions in the Cat
To create areas of demyelination 2 JLl of 0.1 % EB was injected into the dorsal columns using previously described methods. I I To examine the ability of glial cell cultures to enhance oligodendrocyte remyelination 2 JLl of cell suspension at a cell density of 6 x 104/ JLl was injected into the lesion 3 days after injecting EB. Animals were immunosuppressed with cyclosporin (IS mg/kg per day in divided oral doses) and then killed and examined by the same methods used for the rats 18 days after transplantation.
RESULTS
Density-Gradient-Isolated Cat Glial Preparations Contain Cells that Remyelinate Demyelinated Rat Axons
Sixty per cent of the density-gradient-isolated (DGI) cat cells stained with the 04 antibody. When transplanted into inherently non-remyelinating X-irradiated EB lesions made in rats, remyelination was seen only in animals which received immunosuppression, indicating that the observed remyelination was being carried out by the trans planted cells. I o In some sections up to 80% of the axons were surrounded by thin myelin sheaths characteristic of oligodendrocyte remyelination and the mean percentage of oligodendrocyte remyelination for all sections exam ined was 30%. The remyelinated axons were present within a fine network of astrocytic processes (Figs. 1-3) . Only a small number, less than 5%, of axons were remyel inated by Schwann cells.
Cat Glial Cell Preparations Which Resulted in
Remyelination in the Rat Fail to Enhance
Oligodendrocyte Remyelination in Ethidium Bromide Lesions in the Cat
As the results of the above experiment indicated that the DGI glial cell preparation had the potential to generate oli godendrocytes when transplanted into areas of demyel ination in the rat, the cell preparation was injected into EB lesions made in the spinal cord of four immunosuppressed cats. The EB lesion in the cat is spontaneously remyel inated mainly by Schwann cells as a consequence of the extensive EB-induced damage to astrocytes.11 Following the injection of the DGI cell suspension no evidence of enhanced oligodendrocyte remyelination was observed in any animal examined 18 days after transplantation.
Rat Glial Cell Preparations Which Enhance
Remyelination in the Rat also Enhance
Oligodendrocyte Remyelination when Transplanted into Demyelinating Lesions in the Cat
To test whether the failure to observe oligodendrocyte remyelination following the transplantation of the DGI cat glial cells into the EB lesion in the cat was in any way related to some property of the lesion which inhibited oli godendrocyte remyelination, rat glial cell cultures known to be capable of enhancing oligodendrocyte remyelination in the rat were injected into EB lesions made in the spinal cord of cats. A cell preparation prepared from neonatal rat forebrain containing 38% mature Ol-positive oligoden drocytes and 5% A2B5-positive 0-2A progenitors was injected into EB lesions in 4 cats. Two of the animals were immunosuppressed with cyclosporin, 2 received no immunosuppression, while a further 2 animals injected with medium served as controls. An area of oligodendro cyte remyelination was present in the centre of the lesion in the immunosuppressed animals (Fig. 4) . No oligoden drocyte remyelination was observed at this site either in animals injected with medium alone, or in those injected with cells without immunosuppression (Table I) . Taken together these results show that the remyelinated axons in the EB lesion in the cat spinal cord have been myelinated by transplanted rat oligodendrocytes -a finding which demonstrates that oligodendrocyte remyelination can be achieved in the EB lesion in the cat by transplantation of glial cells.
In an attempt to understand why the injection of DGI cells which contained a large number of 04-positive cells failed to enhance remyelination when injected into demyelinating lesions in the cat, the in vitro behaviour of
Figs. 1-3 (opposite). Fig. 1 . Twenty-one days following transplantation (�f neonatal kitten forebrain density-gradient-isolated (DGI) cells into X-irradiated demyelinated lesions in the spinal cord of adult rats. remyelinated axons were seen only in animals that were maintained on immunosuppression. Oligodendrocyte remyelinated axons within the lesion are present within a network of astro eytic processes. Toluidine blue, 1 f-Lm sections. xl000. Fig. 2 . In non-immunosuppressed rats that were transplanted with neonatal kit ten forebrain DGI cells the lesion contained only demyelinated axons and debris-laden macrophages. Toluidine blue, 1 f-Lm sections, xl000. Fig. 3. (a) Electron microscopy of lesions demonstrates thinly myelinated axons in an environment offlll e cell processes. these cells was investigated and further groups of rats with X-irradiated EB lesions were injected with cells which had been maintained in culture for 7, 14 and 21 days.
In Vitro Analysis of the Cells which Develop fr om the DGI Cat Preparations
The results of the phenotypic analysis of the cultures are presented in Fig. 5 . The first full analysis was performed after the cells had been allowed to adhere to the tissue cul ture surface for 2 days, at which time the proportion of 04-positive cells had markedly declined from the 60% which stained with this antibody in cell suspension. At all time points examined, between 60% and 80% of the cells were GFAP-positive and 36-60% of the cells were A2BS-positive (Fig. 6) . Because of the high density of GFAP-positive cell processes, the overlap between A2BS and GFAP staining was difficult to determine at all time points. However, at the earlier time points when cell density was low, over 80% of the A2BS-positive cells were also GF AP-positive. The GF AP-positive cells had long thin processes and no flat GF AP-positive cells were seen at the time points examined.
Remyelination Observed Following Transplantation of Cultured Glial Cells into X-irradiated Ethidium Bromide Lesion in the Rat
The lesions in all the animals which did not receive immu- nosuppression contained only debris-filled macrophages and demyelinated axons. In contrast, all the lesions in immunosuppressed animals were filled with cells; the pro portion of axons surrounded by the thin myelin sheaths which characterise oligodendrocyte remyelination and those associated with Schwann cells was evaluated and the results are presented in Table II. In the animals which received cells which had been in culture for 7 and 21 days, there was some evidence of oli godendrocyte remyelination, up to 15% of demyelinated axons being remyelinated in some sections. No oligo dendrocyte remyelination was observed in the lesions injected with cells that had been in culture for 14 days. Axons remyelinated by Schwann cells occurred in small groups and were found in all animals. The number of Schwann cell remyelinated axons was greatest in the ani mals injected with cells that had been in culture for 7 days. The appearance of the astrocytic environment established in the lesions was similar in all animals, appearing either as a open meshwork of fine cell processes or as compact tissue in which demyelinated axons were surrounded and separated by astrocyte process. The work reported here illustrates how xenografting can be used to examine both the repair capacity of cell prep arations and the repair potential of experimental lesions. However, our attempts to influence the repair of the cat EB lesion by transplanting a feline cell preparation have not so far been successful. The reason for this is not altogether clear. It is apparent that using only the criteria that cat cul tures contain 04 staining cells, or that a culture can remyelinate axons when transplanted into demyelinated lesions in rats, is not sufficient to predict their behaviour when transplanted into similar lesions in the cat. Although a number of differences were noted in the properties of fel ine glia compared with rat glia which may have some bear ing on the outcome following transplantation, our experience with rat-to-rat transplantation has shown the importance of transplanting optimal numbers of cells with an appropriate ratio of astrocytes to oligodendrocyte lineage cells when attempting to re-establish glial environments.2J It is possible, therefore, that the primary reason for failure to enhance oligodendrocyte remyel ination in the cat may have been our failure to transplant cultures with sufficient oligodendrocyte-generating potential. In this regard it is perhaps significant that although small 04 mUltipolar cells, which might represent bipotential glial progenitors, were reappearing in culture at 21 days and reached high numbers by 28 days, no oligo dendrocytes were generated in tissue culture. It may be that feline oligodendrocyte progenitors (04-positive cells) are more susceptible to serum than rat 0-2A progenitors and all the cells were differentiating into astrocytes. Thus, ways to achieve a higher number of oligodendrocyte lineage cells must be sought and the possibility that feline bipotential glial progenitor cells are more sensitive to serum than rat cells needs to be investigated. The sus ceptibility of feline oligodendrocyte lineage cells to serum components such as complement may also need to be addressed, as autologous complement is considered to be toxic for 0ligodendrocytes.19 However, experience of transplanting rodent oligodendrocytes into situations where the blood-brain barrier is disrupted has not been a problem. It is clear that information gained from glial cell transplantation studies in one species is of value when confronted with a different species. However, without a basic understanding of the glial cell biology of that species it becomes difficult to interpret experiments of the type reported here. The progress made with glial cell trans plantation in the rat was underpinned by considerable understanding of glial cell biology in that species and our experiences in the cat have highlighted the difficulties in making progress in the absence of such information.
